BioGlue Used In Over Half a Million Surgeries

CryoLife’s BioGlue Surgical Adhesive has been used in more than 500,000 surgical procedures worldwide since its introduction in 1998.

Read more »

Aureon Featured In TV Segment

Aureon Laboratories, a developer of predictive tests for cancer care, has been featured in a cable television segment produced by the Yonkers Chamber of Commerce.

Read more »

Clarient Files Registration Agreement With SEC

Clarient has filed a registration statement with the Securities and Exchange Commission on Form S-3 relating to shares of Clarient owned by Safeguard.

Read more »

SyntheMed Nominated for Frost & Sullivan Award

The Iselin, NJ-based company was recognized for its REPEL-CV Anti-Adhesion Barrier.

Read more »

CNS Closes $1M Bridge Loan, Completes Clinical Trial Enrollment

The money will allow CNS Response, based in Costa Mesa, Calif., to complete an upcoming depression study.

Read more »

FDA Approves Kowa’s Cambia for Migraines

In clinical trials, Cambia provided statistically significant onset of relief of migraine pain within 15 to 30 minutes.

Read more »

BioNeutral Ships Mold-Fighting Ogiene-M Formulation

BioNeutral, a life science company that specializes in biohazard neutralization technologies, has started shipping its Ogiene-M formulation to fulfill an agreement between BioNeutral and Mr. Mold.

Read more »

Promising Genetic Biomarker Identified for Colorectal Cancer

A new genetic discovery could lead to easier detection of colorectal cancer.

Read more »

Covidien Launches Nationwide Type 2 Diabetes Campaign

The Our Resolution movement is focused around the discovery that gastric bypass surgery resolves diabetes in approximately 77 percent of morbidly obese patients.

Read more »

In3 East: June 23-25, 2009 at the Westin Copley Boston

Hundreds of companies such as Bain Capital Ventures, Becton Dickinson, Covidien, DePuy Mitek Worldwide, Kimberly-Clark, Medtronic, Novartis BioVenture Fund, Quaker […]

Read more »